Cutting Edge Urology

T his PDF belongs to matthew.hooson@springer.co ULTRASOUND MRI FUSION BIOPSY IN PROSTATE GLAND • 45  26. Raskolnikov D, Rais-Bahrami S, George AK et al (2015) The role of image guided biopsy targeting in patients with atypical small acinar proliferation. J Urol 193(2):473–478. 27. ValerioM, Donaldson I, EmbertonM et al (2015) Detection of clinically significant prostate cancer usingmagnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68(1):8–19. 28. Hu JC, Chang E, Natarajan S et al (2014) Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol 192(2):385–390. 29. Sonn GA, Natarajan S, Margolis DJ et al (2013) Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 189(1):86–91. 30. Muller BG, Kaushal A, Sankineni S et al (2015) Multiparametric magnetic resonance imagingtransrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy. Urol Oncol 33(10):425.e1–6. 31. van den Bos W, Muller BG, Ahmed H et al (2014) Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol 65(6):1078–1083. 32. Delongchamps NB, Peyromaure M, Schull A et al (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189(2):493–499. 33. Mozer P, Rouprêt M, Le Cossec C et al (2015) First round of targeted biopsies usingmagnetic resonance imaging/ ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int 115(1):50–57. 34. Rastinehad AR, Turkbey B, Salami SS et al (2014) Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 191(6):1749–1754. 35. Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397. 36. Baco E, Rud E, Eri LM et al (2015) A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69(1):149–56. [Epub ahead of print]. 37. Tonttila PP, Lantto J, Pääkkö E et al (2015) Prebiopsy multiparametric ma netic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostatespecific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69(3):419–25. [Epub ahead of print]. 38. Puech P, Rouvière O, Renard-Penna R et al (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 268(2):461–469. 39. Lanz C, Cornud F, Beuvon F et al (2016) Gleason score determination with TRUS-MRI fusion guided prostate biopsies: are we gaining in accuracy? J Urol 195(1):88–93. [Epub ahead of print]. 40. Radtke JP, Kuru TH, Boxler S et al (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193(1):87–94. 41. Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66(2):343–351. 42. Cool DW, Zhang X, Romagnoli C et al (2015) Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUSguided prostate biopsy. AJR Am J Roentgenol 204(1):83–91. 43. Mouraviev V, Verma S, Kalyanaraman B et al (2013) The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the prelimina ry experience. J Endourol 27(7):820–825. 44. Arsov C, Ra benalt R, Blondin D et al (2015) Prospective randomized trial comparingmagnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasoundguided prostate biopsy in patients with pri or negativ e biopsies. Eur Urol 68(4):713–720. 45. Simmons LA, Ahme d HU , Moore CM et al (2014) The PICTURE study -prostate imaging (multiparametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. Contemp Clin Trials 37(1):69–83. 46. El-Shater Bosaily A, Parker C, Brown LC, et al (2015) PROMIS Group. PROMIS Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer. Contemp Clin Trials 42:26–40. Cutting EDGE_Urology(SUN)_final.indd 45 27-Mar-18 10:00:32 AM